Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
                        AuthID
P-00X-8A8
                
    P-00X-8A8
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service